Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The objective of this study was to investigate the bioequivalence of Mylan\'s verapamil HCl extended-release 300 mg capsules to Schwarz\'s Verelan® PM extended-release 300 mg capsules following evening administration of a single, oral 300 mg (1 x 300 mg) dose under fasting conditions.
Epistemonikos ID: 14e506bcde26d16336a154783bc0cb8ea6748af7
First added on: May 04, 2024